|
Volumn 4, Issue , 1999, Pages 15-34
|
Evolving therapies for the treatment of viral hepatitis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADEFOVIR DIPIVOXIL;
ALPHA INTERFERON;
ALPHA2A INTERFERON;
ALPHA2B INTERFERON;
ALPHAN1 INTERFERON;
BETA INTERFERON;
BETA1A INTERFERON;
COMPLEMENTARY RNA;
CONSENSUS INTERFERON;
DNA VACCINE;
EMITRICITABINE;
EMTRICITABINE;
FAMCICLOVIR;
GANCICLOVIR;
HEPATITIS B VACCINE;
INTERFERON;
INTERFERON BETA SERINE;
LAMIVUDINE;
LOBUCAVIR;
LYMPHOBLAST INTERFERON;
POLYCLONAL ANTIBODY;
RECOMBINANT ALPHA2A INTERFERON;
RECOMBINANT ALPHA2B INTERFERON;
RECOMBINANT GAMMA INTERFERON;
RIBAVIRIN;
UNCLASSIFIED DRUG;
ALOPECIA;
ANEMIA;
DELTA AGENT HEPATITIS;
DEPRESSION;
DIARRHEA;
DRUG STRUCTURE;
FATIGUE;
FEVER;
FLU LIKE SYNDROME;
HEADACHE;
HEMOLYTIC ANEMIA;
HEPATITIS;
HEPATITIS B;
HEPATITIS C;
HEPATITIS E;
HEPATITIS G VIRUS;
HUMAN;
IMMUNITY;
MYALGIA;
NAUSEA;
REVIEW;
RHEUMATOID ARTHRITIS;
SOMNOLENCE;
TERATOGENICITY;
THROMBOCYTOPENIA;
THYROIDITIS;
VIRUS HEPATITIS;
|
EID: 0032908321
PISSN: 13619195
EISSN: None
Source Type: Journal
DOI: 10.1517/14728214.4.1.15 Document Type: Review |
Times cited : (3)
|
References (72)
|